These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 39066214)

  • 41. Identification and impact on
    Forti F; Bertoli C; Cafora M; Gilardi S; Pistocchi A; Briani F
    Microbiol Spectr; 2023 Dec; 11(6):e0147723. PubMed ID: 37966242
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Jumbo phages are active against extensively drug-resistant eyedrop-associated
    Cobián Güemes AG; Ghatbale P; Blanc AN; Morgan CJ; Garcia A; Leonard J; Huang L; Kovalick G; Proost M; Chiu M; Kuo P; Oh J; Karthikeyan S; Knight R; Pogliano J; Schooley RT; Pride DT
    Antimicrob Agents Chemother; 2023 Dec; 67(12):e0065423. PubMed ID: 37931230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections.
    Pires DP; Vilas Boas D; Sillankorva S; Azeredo J
    J Virol; 2015 Aug; 89(15):7449-56. PubMed ID: 25972556
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bacteriophages in sputum of cystic fibrosis patients as a possible cause of in vivo changes in serotypes of Pseudomonas aeruginosa.
    Ojeniyi B
    APMIS; 1988 Apr; 96(4):294-8. PubMed ID: 3130885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A window of opportunity to control the bacterial pathogen Pseudomonas aeruginosa combining antibiotics and phages.
    Torres-Barceló C; Arias-Sánchez FI; Vasse M; Ramsayer J; Kaltz O; Hochberg ME
    PLoS One; 2014; 9(9):e106628. PubMed ID: 25259735
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT.
    Langton Hewer SC; Smyth AR; Brown M; Jones AP; Hickey H; Kenna D; Ashby D; Thompson A; Sutton L; Clayton D; Arch B; Tanajewski Ł; Berdunov V; Williamson PR
    Health Technol Assess; 2021 Nov; 25(65):1-128. PubMed ID: 34806975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phage therapy against Pseudomonas aeruginosa infections in a cystic fibrosis zebrafish model.
    Cafora M; Deflorian G; Forti F; Ferrari L; Binelli G; Briani F; Ghisotti D; Pistocchi A
    Sci Rep; 2019 Feb; 9(1):1527. PubMed ID: 30728389
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients.
    Olszak T; Zarnowiec P; Kaca W; Danis-Wlodarczyk K; Augustyniak D; Drevinek P; de Soyza A; McClean S; Drulis-Kawa Z
    Appl Microbiol Biotechnol; 2015 Jul; 99(14):6021-33. PubMed ID: 25758956
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A synthetic biology approach to assemble and reboot clinically relevant
    Ipoutcha T; Racharaks R; Huttelmaier S; Wilson CJ; Ozer EA; Hartmann EM
    Microbiol Spectr; 2024 Mar; 12(3):e0289723. PubMed ID: 38294230
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bacteriophages of Pseudomonas aeruginosa: long-term prospects for use in phage therapy.
    Krylov VN
    Adv Virus Res; 2014; 88():227-78. PubMed ID: 24373314
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two Novel Bacteriophages Improve Survival in
    Jeon J; Yong D
    Appl Environ Microbiol; 2019 May; 85(9):. PubMed ID: 30824445
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Augmentation of the antimicrobial efficacy of antibiotics by filamentous phage.
    Hagens S; Habel A; Bläsi U
    Microb Drug Resist; 2006; 12(3):164-8. PubMed ID: 17002542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emerging Phage Resistance in
    Markwitz P; Olszak T; Gula G; Kowalska M; Arabski M; Drulis-Kawa Z
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372538
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic determinants of antimicrobial resistance in polymyxin B resistant Pseudomonas aeruginosa isolated from airways of patients with cystic fibrosis.
    Simão FA; Almeida MM; Rosa HS; Marques EA; Leão RS
    Braz J Microbiol; 2024 Jun; 55(2):1415-1425. PubMed ID: 38619733
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Engineered Superinfective Pf Phage Prevents Dissemination of Pseudomonas aeruginosa in a Mouse Burn Model.
    Prokopczuk FI; Im H; Campos-Gomez J; Orihuela CJ; Martínez E
    mBio; 2023 Jun; 14(3):e0047223. PubMed ID: 37039641
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exploiting lung adaptation and phage steering to clear pan-resistant Pseudomonas aeruginosa infections in vivo.
    Ashworth EA; Wright RCT; Shears RK; Wong JKL; Hassan A; Hall JPJ; Kadioglu A; Fothergill JL
    Nat Commun; 2024 Feb; 15(1):1547. PubMed ID: 38378698
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of hypermutation and collateral sensitivity in antimicrobial resistance diversity of
    Vanderwoude J; Azimi S; Read TD; Diggle SP
    mBio; 2024 Feb; 15(2):e0310923. PubMed ID: 38171021
    [No Abstract]   [Full Text] [Related]  

  • 58. Antibacterial efficacy of lytic phages against multidrug-resistant Pseudomonas aeruginosa infections in bacteraemia mice models.
    Arumugam SN; Manohar P; Sukumaran S; Sadagopan S; Loh B; Leptihn S; Nachimuthu R
    BMC Microbiol; 2022 Aug; 22(1):187. PubMed ID: 35909125
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selection of phages and conditions for the safe phage therapy against Pseudomonas aeruginosa infections.
    Krylov V; Shaburova O; Pleteneva E; Krylov S; Kaplan A; Burkaltseva M; Polygach O; Chesnokova E
    Virol Sin; 2015 Feb; 30(1):33-44. PubMed ID: 25680443
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The susceptibility of Pseudomonas aeruginosa strains from cystic fibrosis patients to bacteriophages.
    Essoh C; Blouin Y; Loukou G; Cablanmian A; Lathro S; Kutter E; Thien HV; Vergnaud G; Pourcel C
    PLoS One; 2013; 8(4):e60575. PubMed ID: 23637754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.